Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies
- PMID: 22271810
Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is a common major dose-limiting side effect of many chemotherapeutic agents, including platinum compounds, taxanes, vinca alkaloids, thalidomide and newer agents such as bortezomib. The incidence and degree of neuropathy depends on the type of cytotoxic drug, the duration of administration, cumulative dose and pre-existing peripheral neuropathy. Because of increasing survival rates of patients treated with neurotoxic agents, CIPN is accompanied by a significant decrease in the patient's quality of life among cancer survivors. Therefore, several neuroprotective strategies, including calcium/magnesium infusion, amifostine, gluthatione, glutamine, acetyl-L-carnitine and erythropoietin as most promising, have been investigated to decrease the neurotoxicity without compromising anti-tumour efficacy. However, clinical evidence for the efficacy of these drugs is sparse. In this review we will give an outline of the neurotoxic effects of chemotherapeutic agents, their clinical manifestations and potential neuroprotective strategies.
Similar articles
-
Chemotherapy-induced neuropathy: A comprehensive survey.Cancer Treat Rev. 2014 Aug;40(7):872-82. doi: 10.1016/j.ctrv.2014.04.004. Epub 2014 Apr 18. Cancer Treat Rev. 2014. PMID: 24830939 Review.
-
Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents.J BUON. 2010 Jul-Sep;15(3):435-46. J BUON. 2010. PMID: 20941808 Review.
-
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.Eur J Cancer. 2008 Jul;44(11):1507-15. doi: 10.1016/j.ejca.2008.04.018. Epub 2008 Jun 18. Eur J Cancer. 2008. PMID: 18571399 Review.
-
Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.Crit Rev Oncol Hematol. 2012 Apr;82(1):51-77. doi: 10.1016/j.critrevonc.2011.04.012. Epub 2011 Sep 10. Crit Rev Oncol Hematol. 2012. PMID: 21908200 Review.
-
Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.Ann Pharmacother. 2008 Oct;42(10):1481-5. doi: 10.1345/aph.1L179. Epub 2008 Aug 12. Ann Pharmacother. 2008. PMID: 18698011 Review.
Cited by
-
Neuropathic cancer pain: What we are dealing with? How to manage it?Onco Targets Ther. 2014 Apr 17;7:599-618. doi: 10.2147/OTT.S60995. eCollection 2014. Onco Targets Ther. 2014. PMID: 24790459 Free PMC article. Review.
-
Effect of Vitamin E on Oxaliplatin-induced Peripheral Neuropathy Prevention: A Randomized Controlled Trial.Int J Prev Med. 2015 Nov 2;6:104. doi: 10.4103/2008-7802.169021. eCollection 2015. Int J Prev Med. 2015. PMID: 26682028 Free PMC article.
-
Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse.Neuropharmacology. 2017 May 1;117:305-315. doi: 10.1016/j.neuropharm.2017.02.020. Epub 2017 Feb 22. Neuropharmacology. 2017. PMID: 28237807 Free PMC article.
-
Model-based clustering for identifying disease-associated SNPs in case-control genome-wide association studies.Sci Rep. 2019 Sep 23;9(1):13686. doi: 10.1038/s41598-019-50229-6. Sci Rep. 2019. PMID: 31548641 Free PMC article.
-
Insights into platinum-induced peripheral neuropathy-current perspective.Neural Regen Res. 2020 Sep;15(9):1623-1630. doi: 10.4103/1673-5374.276321. Neural Regen Res. 2020. PMID: 32209761 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
